| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/16/2009 | CN101531800A Method for preparing poly(amidoamine)/carbon nanometer tube composite material for cancer cell targeting diagnosis |
| 09/15/2009 | US7588887 Stable isotope metabolic labeling for analysis of biopolymers |
| 09/15/2009 | US7588780 Embolization |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | US7588751 Mixing a sterol or a polyether modified phospholipid capable of forming a liposome with a supercritical carbon dioxide, contacting water-soluble nonionic iodine compound with phospholipid to form a liposome containing vesicles including the iodine compound; chlorine-free solvent |
| 09/15/2009 | CA2522563C Methods of producing carbon-13 labeled biomass |
| 09/15/2009 | CA2459924C Process for preparing concentrate thickener compositions |
| 09/15/2009 | CA2440650C Photosensitizer and method for production thereof |
| 09/15/2009 | CA2440372C Preparation for determining pyrimidine metabolic capacity |
| 09/15/2009 | CA2421931C Hydrophilic, lubricious medical devices having contrast for magnetic resonance imaging |
| 09/11/2009 | WO2009111508A2 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 09/11/2009 | WO2009111470A2 Protease assay |
| 09/11/2009 | WO2009111273A2 Peptide targeting imaging agents and methods of use thereof |
| 09/11/2009 | WO2009110984A2 Contrast agents for applications including perfusion imaging |
| 09/11/2009 | WO2009110523A2 Dendrimer particle, mri contrast medium, and method of manufacturing a dendrimer particle |
| 09/11/2009 | WO2009109588A2 Mixed ligand core/shell iron oxide nanoparticles for inflammation imaging |
| 09/11/2009 | WO2009109569A2 Ester imaging agents |
| 09/11/2009 | WO2006004907A3 Methods of inhibiting viral replication |
| 09/11/2009 | CA2717803A1 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 09/11/2009 | CA2717563A1 Protease assay |
| 09/11/2009 | CA2716354A1 Contrast agents for applications including perfusion imaging |
| 09/10/2009 | US20090226378 Coded medications and methods of preparing same for identification and distinguishment |
| 09/10/2009 | US20090226377 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors |
| 09/10/2009 | US20090226376 Novel Mixed Ligand Core/Shell Iron Oxide Nanoparticles for Inflammation Imaging |
| 09/10/2009 | US20090226375 MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION AND USES THEREOF |
| 09/10/2009 | US20090226374 Anaphylatoxins for detecting clinical conditions |
| 09/10/2009 | US20090226373 Method of determining the effect of a spill on a marine environment |
| 09/10/2009 | US20090226372 Methods and compositions related to peptides and proteins with c-terminal elements |
| 09/10/2009 | US20090226371 Fluorescent nanoparticles |
| 09/10/2009 | US20090226370 GEP, a novel chondrogenic growth factor and target in cartilage disorders |
| 09/10/2009 | US20090226369 STQ Peptides |
| 09/09/2009 | EP2098522A1 Novel compound having affinity for amyloid |
| 09/09/2009 | EP2097536A2 Systems and methods for in vivo measurement of interstitial biological activity, processes and/or compositions |
| 09/09/2009 | EP2097439A1 Novel peptides |
| 09/09/2009 | EP2097438A1 Fibrin binding peptide conjugates for diagnostic and therapeutic applications. |
| 09/09/2009 | EP2097109A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 09/09/2009 | EP2007434A4 Method and system for determining whether a drug will be effective on a patient with a disease |
| 09/09/2009 | EP1648925B1 Bicyclic peptide imaging agents |
| 09/09/2009 | EP1578958B1 Method for suppressing immune system response to transplanted tissue or cells |
| 09/09/2009 | EP1553923B1 Camptothecin-carboxylate formulations |
| 09/09/2009 | CN101528268A Gas-filled microvesicles with polymer-modified lipids |
| 09/09/2009 | CN101528267A Contrast agents for detecting prostate cancer |
| 09/09/2009 | CN101525384A A bispecific antibody and the making method and the application thereof |
| 09/09/2009 | CN101524526A New application of LSECtin |
| 09/09/2009 | CN101524290A Intraluminal tissue markers |
| 09/09/2009 | CN100536925C Emulsion spray drying method for preparing ultrasound microbubble contrast agent in batch |
| 09/08/2009 | US7585509 Erb-2 receptor targeting peptide |
| 09/08/2009 | US7585492 Contrast agents used in various embodiments may be any organic or semi-organic compounds which have the desired effect of affinity to certain target tissues/cells to either bind with them or react with them or react with metabolic products of the target; dosage monitoring and therapy success mechanism |
| 09/08/2009 | CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/03/2009 | WO2009108376A2 Contrast agents for applications including perfusion imaging |
| 09/03/2009 | WO2009107139A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors |
| 09/03/2009 | WO2009106566A2 Therapy selection method |
| 09/03/2009 | WO2009106552A2 Contrast agents |
| 09/03/2009 | WO2009106551A2 Contrast agents |
| 09/03/2009 | WO2008148877A3 Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function |
| 09/03/2009 | US20090222933 Human Liver Cancer Cell Line |
| 09/03/2009 | US20090221891 Optical sensor for in vivo detection of analyte |
| 09/03/2009 | US20090221799 Novel Fluorescent and Colored Proteins, and Polynucleotides That Encode These Proteins |
| 09/03/2009 | US20090221793 Process for preparing a pentopyranosyl nucleic acid conjugate |
| 09/03/2009 | US20090221442 Substrates and screening methods for transport proteins |
| 09/03/2009 | US20090220618 Pharmaceutical formulations comprising polyanionic materials and source of hydrogen peroxide |
| 09/03/2009 | US20090220434 Nanoparticles that facilitate imaging of biological tissue and methods of forming the same |
| 09/03/2009 | US20090220433 Novel biotinylated compositions |
| 09/03/2009 | US20090220432 Imaging agents and methods of using same for detecting multidrug resistance in cancer |
| 09/03/2009 | US20090220431 Magnetic resonance imaging contrast agents containing water-soluble nanoparticles of manganese oxide or manganese metal oxide |
| 09/03/2009 | US20090220430 Fluorescent Imaging Agents |
| 09/03/2009 | US20090220429 Method and a system for assessing neurological conditions |
| 09/03/2009 | US20090220428 Insect Repellent and Process for Identifying Other Insect Repellent Molecules |
| 09/03/2009 | US20090220427 Drug Resistance and Methods of Reversing |
| 09/03/2009 | US20090220424 Pro104 Antibody Compositions and Methods of Use |
| 09/03/2009 | US20090220423 Method of activating a photosensitizer |
| 09/03/2009 | US20090220422 Drug Delivery Material |
| 09/03/2009 | US20090220421 Method for screening mtp-inhibiting compounds |
| 09/03/2009 | US20090220420 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr) |
| 09/03/2009 | US20090220418 Multimodal imaging using a three compartment polymer nanoparticle with cell specificity |
| 09/03/2009 | US20090220417 Methods of using il-31 monoclonal antibodies to reduce inflammation |
| 09/03/2009 | CA2717060A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors |
| 09/03/2009 | CA2716501A1 Crystal forms of 2-{2-[(cyclohexyl)methylene]hydrazino}adenosine |
| 09/03/2009 | CA2657016A1 Intraluminal tissue markers |
| 09/02/2009 | EP2094640A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar). |
| 09/02/2009 | EP2094311A2 Improved linkers for anchoring targeting ligands |
| 09/02/2009 | EP2094310A2 Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production |
| 09/02/2009 | EP1684807B1 Method of identifying responders to treatment with insulin sensitizers |
| 09/02/2009 | EP1472259B1 Tetrapyrrolic macrocycles as photodynamic agents |
| 09/02/2009 | EP1189645B1 Non-covalent bioconjugates useful for diagnosis and therapy |
| 09/02/2009 | EP0995448B1 Compound for diagnosing malignant tumors |
| 09/02/2009 | CN101519387A Thiophenylamine derivative two-photon biological developing material |
| 09/02/2009 | CN101518656A Amphiphilic superparamagnetism magnetic resonance contrast medium and preparation method thereof |
| 09/02/2009 | CN101518528A Application of carbocyanine dye near infrared fluorescent compound |
| 09/02/2009 | CN100534534C Method for improving oxygen transport by stored red blood cells |
| 09/01/2009 | US7582283 Contrast agents to improve gastrointestinal tract opacification during abdominal and pelvic CT scans |
| 09/01/2009 | US7582280 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications |
| 09/01/2009 | US7582279 Surface modified lipoprotein-like oil in water emulsion having lipophilic core surrounded by monolayer of amphiphilic or polar lipids; polyoxyethylene glycol linked lipid and (choles)terol; radioactive or stable, synthetic polyhalogenated triglycerides as contrast agents; radiographic imaging |
| 08/27/2009 | WO2009105671A2 Methods and compositions related to peptides and proteins with c-terminal elements cross-reference to related applications |
| 08/27/2009 | WO2009103744A2 Process for preparing a pharmaceutical formulation of contrast agents |
| 08/27/2009 | WO2009103741A2 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 08/27/2009 | WO2009050447A3 Water-based skin products |
| 08/27/2009 | US20090214669 Combination anticancer therapy and pharmaceutical compositions therefore |
| 08/27/2009 | US20090214532 ANKTM1, A Cold-Activated TRP-Like Channel Expressed in Nociceptive Neurons |
| 08/27/2009 | US20090214439 Fluorinated Carbohydrates and Their Use in Tumor Visualization, Tissue Engineering, and Cancer Chemotherapy |